Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training

Sponsor
Kessler Foundation (Other)
Overall Status
Recruiting
CT.gov ID
NCT05130658
Collaborator
(none)
30
1
3
24
1.3

Study Details

Study Description

Brief Summary

The purpose of this research study is to test the effectiveness of virtual reality (VR) based treadmill training on walking ability. The study will also help to understand the changes in cognitive ability and brain activity as a result of VR-based treadmill training after a brain injury.

The study will include 3 groups: C-MILL training group (CTG), Treadmill training group (TTG), and healthy control group (HCG).

Individuals with brain injury will be randomly assigned to C-MILL training group, or Treadmill training group.

The CTG and TTG will participate in up to 13 sessions. The participants will be screened for the inclusion/exclusion criteria and consented during the first session. They will participate in two data collection sessions, one before the training and one after the training. The participants will undergo 10 training sessions. Individuals in the CTG will receive gait and balance training sessions with the virtual reality and auditory cues using C-MILL (such as walking on a pathway, obstacle avoidance, lateral balance etc.) to provide task specific training. C-Mill (Motekforce Link, Amsterdam, The Netherlands) is an instrumented treadmill that uses visual (on the screen as well on the treadmill) and acoustic cues for gait and balance training. The C-Mill allows for gait and balance adaptability strategy as it can provide obstacle avoidance environments, change in speed and various walking pathways in a safe and controlled environment.

Individuals in TTG group will walk on the treadmill (C-MILL) or stand on the treadmill (C-MILL) with no visual or auditory cues.

HCG will participate in up to four sessions. The participants will be screened for the inclusion/exclusion criteria and consented during the first session. They will participate in two data collection sessions and one C-MILLsession.

Each training session will last for 45 minutes. During the 45 minutes, the participants will perform the task for approximately 1 minute. Participants will be allowed as much rest as needed by them.

During the training all participants will wear the safety harness to protect from falling. In addition spotter will be present with the participants to prevent falls.

Data Collection:

Each participant's baseline and follow up data will be collected for a) functional b) neuromechanical c) cortical and d) cognitive outcomes. During walking on treadmill data will also be collected with instrumented C- MILL. C-MILL can provide gait parameters such as step length, width, frequency, speed and symmetry in addition to center of pressure for evaluation of gait and balance.

During Training Sessions: The instrumented treadmill will collect force data during training.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual reality treadmill training
  • Other: Treadmill Training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pilot Study to Improve Ambulation in Individuals With Traumatic Brain Injury (TBI) Using Virtual Reality -Based Treadmill Training
Actual Study Start Date :
Sep 30, 2020
Anticipated Primary Completion Date :
Sep 29, 2022
Anticipated Study Completion Date :
Sep 29, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: C-MILL training group

The participants will be screened for the inclusion/exclusion criteria and consented during the first session. They will participate in two data collection sessions, one before the training and one after the training. The participants will undergo 10 training sessions. Individuals in the CTG will receive gait and balance training sessions with the virtual reality and auditory cues using C-MILL (such as walking on a pathway, obstacle avoidance, lateral balance etc.) to provide task specific training. C-Mill (Motekforce Link, Amsterdam, The Netherlands) is an instrumented treadmill that uses visual (on the screen as well on the treadmill) and acoustic cues for gait and balance training. The C-Mill allows for gait and balance adaptability strategy as it can provide obstacle avoidance environments, change in speed and various walking pathways in a safe and controlled environment.

Device: Virtual reality treadmill training
C-Mill (Motekforce Link, Amsterdam, The Netherlands) is an instrumented treadmill that uses visual (on the screen as well on the treadmill) and acoustic cues for gait and balance training. The C-Mill allows for gait and balance adaptability strategy as it can provide obstacle avoidance environments, change in speed and various walking pathways in a safe and controlled environment.
Other Names:
  • C-MILL training, C-Mill (Motek, the Netherlands)
  • Active Comparator: Treadmill training group (TTG)

    The participants will be screened for the inclusion/exclusion criteria and consented during the first session. They will participate in two data collection sessions, one before the training and one after the training. The participants will undergo 10 training sessions. Individuals in TTG group will walk on the treadmill (C-MILL) or stand on the treadmill (C-MILL) with no visual or auditory cues.

    Other: Treadmill Training
    Conventional gait and balance training using treadmill.

    No Intervention: Healthy Control

    HCG will participate in up to four sessions. The participants will be screened for the inclusion/exclusion criteria and consented during the first session. They will participate in two data collection sessions and one C-MILL session.

    Outcome Measures

    Primary Outcome Measures

    1. Change in Dynamic Gait Index (DGI) [5 weeks]

      DGI is a measurement tool commonly used to assess dynamic balance, gait and risk for falls. It consist of a total of eight gait assessments which can be scored on a four-point ordinal scale, ranging from 0-3, where '0' indicates the lowest level of function and '3' the highest level of function, allowing for a total possible score of 24.

    2. Change in Timed Up and Go (TUG) [5 weeks]

      TUG is a clinical test of functional gait abilities and dynamic balance. The participants will be asked to walk a distance of 3 meters from a seated position, turn around, walk back to the chair and sit back in the chair. The time taken to perform the task will be recorded using a stop watch. The TUG will be repeated multiple times. The participant may be asked to hold a plastic cup or count backwards by three from a randomly selected number while walking.

    3. Change in Six Minute Walk [5 weeks]

      Participants walk as far as possible for 6 minutes. They walk back and forth around the cones along an unobstructed pathway of 15 meters. They will be permitted to slow down or stop as necessary. The distance covered by the participant for the 6 minutes will be recorded at an interval of every 30 seconds using a measuring wheel and stop watch.

    4. Change in Ten Meter Walk Test [5 weeks]

      This is a walking test. I will be asked to walk as fast as I can at a safe speed for 10 meters (about 10 yards).

    5. Change in Temporal Characteristics using pressure mat [5 weeks]

      Participants will be asked to walk about 10 meters on a pressure mat. Pressure mat (ZenoMat, Protokinetics LLC) will be used to collect gait cycle times, in order to determine inter- and intra-limb temporal characteristics.

    6. Change in Spatial Characteristics [5 weeks]

      Participants will be asked to walk about 10 meters on a pressure mat. Pressure mat (ZenoMat, Protokinetics LLC) will be used to collect spatial parameters, in order to determine inter- and intra-limb spatial characteristics.

    7. Change in Silver Index [5 weeks]

      Silver index using Movendo Technology platform (Movendo Technology Srl,, Italy) is an objective test that enables to predict falls by assessing static and dynamic balance. Participants will be asked to stand on the Hunova platform. Silver index includes the following tasks: stand with eyes open or eyes closed, stand when the surface is perturbed, move torso on all four sides, perform sit to stand.

    8. Change in Cortical Activity [5 weeks]

      Cortical activity will be measured using 16 channel NIRSport 2 (NIRX Medical Technologies, LLC ), an Functional Near Infrared Spectroscopy (fNIRS) system. NIRSport 2 is a portable, non-invasive optical imaging technique to measure the cerebral hemodynamic response. fNIRS will be measure while the participants walks at a comfortable speed.

    9. Change in Trail Making Test A and B [5 weeks]

      The task requires a subject to connect a sequence of 25 consecutive targets on a sheet of paper. Trail making Test A and B assess processing speed and executive function.

    10. Change in Montreal Cognitive Assessment Test [5 weeks]

      30-item question to assess cognitive impairment. MoCA is used to test orientation, attention, memory, and executive function.

    Secondary Outcome Measures

    1. Change in Gait Kinematics [5 weeks]

      Natural Point's optitrack camera system will be used to collect joint angles at hip, knee and ankle using reflective markers placed on the anatomical joints.

    2. Change in Electromyography [5 weeks]

      Noraxon's surface Electromyography (EMG) wireless sensors will be used to measure the activation of tibialis anterior, soleus, vastus lateralis, rectus femoris, bicep femoris, and gastrocnemius during walking.

    3. Change in Continuous Performance Task (CPT) [5 weeks]

      The test requires a subject to click only when presented with a target. They must refrain from clicking if they see anything other than the target. To increase the difficulty, they will be asked to click if they see another stimuli before the target. CPT assesses sustained and selective attention.

    4. Change in C-MILL Force Data [10 training sessions]

      Force data during walking and standing will be collected during training sessions by the C-MILL

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years to 35 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion/exclusion criteria for TBI:
    Inclusion Criteria:
    Participants must:
    • Be TBI survivors > 6 months post TBI

    • Be able to tolerate upright standing for up to 30 minutes.

    • Have joint range of motion within normal functional limits for walking as determined by study staff.

    • Be between 13-35 years of age.

    • Be able to follow directions and commands.

    • Be able to communicate in English.

    • Have stable blood pressure.

    • Not been diagnosed with any cognitive (thinking) deficits.

    Exclusion Criteria:
    • Weight above 300lbs.

    • Joint contracture or spasticity of any limb that limits normal range of motion during ambulation with assistive devices.

    • Have any medical issue that prevents from supporting his/her weight (e.g. orthopedic injuries, pain, or severe spasticity).

    • Have pre-existing condition that causes exercise intolerance (e.g. documented uncontrolled hypertension, coronary artery disease, irregular heart rate or rhythm, or congestive heart failure).

    • Skin issues that would prevent from wearing a harness.

    • Have been hospitalized for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study.

    • Have uncontrolled seizure disorder.

    • Have uncontrolled spasticity that would interfere with walking.

    • Diagnosed with cognitive (thinking) problems prior to TBI.

    • Have neuromuscular or neurological issues (e.g. spinal cord injury, multiple sclerosis, or Parkinson's disease)

    Inclusion/exclusion criteria for Healthy controls:
    Inclusion Criteria:
    Participants must:
    • Be able to tolerate upright standing for up to 30 minutes.

    • Have joint range of motion within normal functional limits for ambulation.

    • No history of orthopedic, neuromuscular, cognitive or neurological disorders.

    • Be between 13-35 years of age.

    • Have stable blood pressure; no diagnosis of persistent orthostatic hypotension (blood pressure drop of more than 30 millimeters of Mercury in body weight support system).

    • No diagnosed cognitive deficits.

    Exclusion Criteria:
    • Weight above 300lbs

    • Joint contracture or spasticity of any limb that limits normal range of motion during ambulation with assistive devices.

    • Any medical issue that precludes full weight bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity).

    • Pressure sore that would negatively affect weight bearing, or harness fit.

    • Pre-existing condition that causes exercise intolerance.(Documented uncontrolled hypertension, coronary artery disease, cardiac arrhythmia, or congestive heart failure)

    • Hospitalization for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study.

    • Uncontrolled seizure disorder.

    • Uncontrolled spasticity that would interfere with walking due to neuromuscular or neurological pathologies (e.g., Parkinson's disease, spinal cord injury, or multiple sclerosis) that will interfere with ambulation, or limit the range of motion of the lower limbs

    • Diagnosed with cognitive deficits.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kessler Foundation West Orange New Jersey United States 07052

    Sponsors and Collaborators

    • Kessler Foundation

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kessler Foundation
    ClinicalTrials.gov Identifier:
    NCT05130658
    Other Study ID Numbers:
    • R-1125-20
    First Posted:
    Nov 23, 2021
    Last Update Posted:
    Nov 23, 2021
    Last Verified:
    Nov 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 23, 2021